Prostaglandin F2α treatment concurrent with artificial insemination does not affect bovine embryo production / Administração de prostaglandina F2 alfa no momento da inseminação artificial não afeta a produção de embriões bovinos

ABSTRACT: Treatment with prostaglandin F2α (PGF) induces ovulation and increases conception rates in cows, while improving embryo production in buffalos. However, its effect on superovulated cows is unknown. This study verified whether single PGF administration concurrent with artificial insemination (AI) improves fertilization and embryo production rates in superovulated cows. In each replicate, embryo donor cows were equally allocated to two groups: the untreated control and PGF groups. The latter of which received 482 µg of cloprostenol concurrent with the first AI. Each cow (n = 35) was subjected to two superovulations (SOV) in a crossover design (total = 70 embryo collections). In the control and PGF groups, respectively, the observed responses were [median (95% CI)]: 12 (10-18) and 15 (12-18) total structures, 9 (7-11) and 7 (6-10) viable embryos, 1 (0-1) and 1 (1-3) degenerated embryos, and 1 (0-3) and 2 (0-5) oocytes (P > 0.05). In conclusion, single PGF treatment concurrent with the first AI did not affect embryo production in superovulated cows.

RESUMO: A prostaglandina F2α (PGF) pode induzir a ovulação e melhorar tanto a concepção em vacas, como a produção de embriões em búfalas, mas o efeito em vacas superovuladas é desconhecido. Esse estudo teve como objetivo verificar se a administração de uma dose de PGF na inseminação artificial (IA) após a superovulação (SOV) melhora as taxas de fecundação e produção embrionária em vacas. Em cada replicação, vacas doadoras de embriões foram equilibradamente alocadas em dois grupos: controle, não tratado, ou PGF, que recebeu 482 µg de cloprostenol no momento da primeira IA. Cada doadora (n = 35) foi submetida a duas SOV em um delineamento crossover (total = 70 coletas de embriões). Nos grupos controle e PGF, respectivamente, foram observados [medianas (IC 95%)]: 12 (10-18) e 15 (12-18) estruturas totais; 9 (7-11) e 7 (6-10) embriões viáveis; 1 (0-1) e 1 (1-3) embriões degenerados; e 1 (0-3) e 2 (0-5) ovócitos (P > 0,05). Conclui-se que uma única administração de PGF no momento da primeira IA não afeta a produção embrionária de vacas superovuladas.

Prostaglandin F2α treatment concurrent with artificial insemination does not affect bovine embryo production / Administração de prostaglandina F2 alfa no momento da inseminação artificial não afeta a produção de embriões bovinos

Treatment with prostaglandin F2α (PGF) induces ovulation and increases conception rates in cows, while improving embryo production in buffalos. However, its effect on superovulated cows is unknown. This study verified whether single PGF administration concurrent with artificial insemination (AI) improves fertilization and embryo production rates in superovulated cows. In each replicate, embryo donor cows were equally allocated to two groups: the untreated control and PGF groups. The latter of which received 482 µg of cloprostenol concurrent with the first AI. Each cow (n = 35) was subjected to two superovulations (SOV) in a crossover design (total = 70 embryo collections). In the control and PGF groups, respectively, the observed responses were [median (95% CI)]: 12 (10-18) and 15 (12-18) total structures, 9 (7-11) and 7 (6-10) viable embryos, 1 (0-1) and 1 (1-3) degenerated embryos, and 1 (0-3) and 2 (0-5) oocytes (P > 0.05). In conclusion, single PGF treatment concurrent with the first AI did not affect embryo production in superovulated cows.

A prostaglandina F2α (PGF) pode induzir a ovulação e melhorar tanto a concepção em vacas, como a produção de embriões em búfalas, mas o efeito em vacas superovuladas é desconhecido. Esse estudo teve como objetivo verificar se a administração de uma dose de PGF na inseminação artificial (IA) após a superovulação (SOV) melhora as taxas de fecundação e produção embrionária em vacas. Em cada replicação, vacas doadoras de embriões foram equilibradamente alocadas em dois grupos: controle, não tratado, ou PGF, que recebeu 482 µg de cloprostenol no momento da primeira IA. Cada doadora (n = 35) foi submetida a duas SOV em um delineamento crossover (total = 70 coletas de embriões). Nos grupos controle e PGF, respectivamente, foram observados [medianas (IC 95%)]: 12 (10-18) e 15 (12-18) estruturas totais; 9 (7-11) e 7 (6-10) embriões viáveis; 1 (0-1) e 1 (1-3) embriões degenerados; e 1 (0-3) e 2 (0-5) ovócitos (P > 0,05). Conclui-se que uma única administração de PGF no momento da primeira IA não afeta a produção embrionária de vacas superovuladas.

Efficiency and accuracy of different ovulation inducers after progesterone device removal in crossbred multiparous cows / Eficiência e acurácia de diferentes indutores de ovulação após a remoção do dispositivo de progesterona em vacas mestiças multíparas

The aim of this study was to verify the efficiency and ovulation time after the administration of different inducers for synchronization of ovulation in beef cows. One hundred and eight non-lactating cows were distributed into the control group (CG; untreated; n=28), estradiol benzoate (EB) group (EBG; n=28); 17 beta-estradiol (17ßE) group (17ßEG; n=28), and deslorelin (DES) group (DESG; n=24). On day minus 11 (D-11) of the protocol, the CG underwent application of cloprostenol and ultrasound examination (US); on D0, progesterone (P4) was inserted plus EB; on D7, cloprostenol was applied; on D9, P4 was removed and cloprostenol plus 400 IU of equine chorionic gonadotropin (eCG) was injected. The EBG was subjected to treatment identical to that of the CG, except on D10, when the cows received EB. The 17ßE was subjected to the same protocol used in the CG except for the administration of 17ßE on D10. And, the DESG was subjected to the same treatment as the CG, except on D10, when the group received DES acetate. Twelve hours after the administration of EB, 17ßE and DES, ovarian US were performed every 6 hours. The preovulatory follicle (POF) diameters measured before ovulation were 19.5; 14.7; 18.7 and 19.8 mm respectively for CG, EBG, 17ßEG and DESG; and the time intervals between inducer application and ovulation were 20.2; 18.9; 21.0 and 22.5 hours respectively. In conclusion, all ovulation inducers were efficient in promoting ovulation; the inducers caused ovulation between 18.9 and 22.5 hours; EB promoted ovulation in a shorter time (P<0.05); 17ßE and DES showed greater variation in application/ovulation time between groups.

O objetivo do estudo foi verificar a eficiência e a ovulação após a administração de diferentes indutores para a sincronização da ovulação em vacas de corte. Cento e oito vacas não-lactantes foram distribuídas em grupo controle (GC; não tratadas; n=28); grupo benzoato de estradiol (BE) (GBE; n=28); grupo 17 beta-estradiol (17ßE) (G17ßE; n=28) e grupo deslorelina (DES) (GDES; n=24). No dia menos 11 (D-11) do protocolo, o GC recebeu cloprostenol e exame ultrassonográfico (US); ao D0, dispositivo de progesterona (P4) foi inserido mais BE; ao D7, cloprostenol foi aplicado; ao D9, a P4 foi removida e cloprostenol mais 400 UI de gonadotrofina coriônica equina (eCG) foi injetada. O GBE foi submetido a tratamento idêntico ao do GC, exceto ao D10, quando as vacas receberam BE. o G17ßE foi submetido ao mesmo protocolo usado no CG exceto pela administração de 17ßE ao D10. E, o GDES foi submetido ao mesmo tratamento que o CG, exceto ao D10, quando o grupo recebeu o acetato de DES. Doze horas após a administração de BE, 17ßE e DES, US ovarianos foram realizados a cada 6 horas. O diâmetro do folículo pré-ovulatório (FPO) medido antes da ovulação foi de 19,5; 14,7; 18,7 e 19,8 mm respectivamente para GC, GBE, G17ßE e GDES; e o intervalo de tempo entre a aplicação do indutor e ovulação foi 20,2; 18,9; 21;0 e 22,5 horas respectivamente. Em conclusão, todos os indutores da ovulação foram eficientes em promover a ovulação; os indutores acarretaram ovulação entre 18,9 e 22,5 horas; o BE promoveu a ovulação em menor espaço de tempo (P<0,05); 17ßE e DES demonstraram maior variação em aplicação/tempo de ovulação entre os grupos.

Reproductive performance of fixed-time artificial insemination in heifers supplemented with a homeopathic complex / Desempenho reprodutivo à inseminação artificial em tempo fixo em novilhas suplementadas com complexo homeopático

For this study, ½ blood Nelore × Aberdeen Angus heifers (n = 40; 14 months) were divided into two groups: control (n=20; 310 kg) and Pró-Cio (n=20; 304 kg). For Pró-Cio group, 20g of homeopathic product (Pró-cio®, Real H, Campo Grande, Brazil) was supplied together with corn eighteen days prior (D-18) to the beginning of the fixed-time artificial insemination protocol (FTAI). On D0, all females received an intravaginal P4 device and 2 mg BE. On D5, the AFC was assessed by ultrasound and blood was collected for AMH dosage. On D8, P4 device was removed; 300 IU eCG, 0.530 mg of cloprostenol sodium and 0.5 mg of EC were administered; an estrus-identifying adhesive was fixed at the tail insertion and the diameter of the dominant follicle (DF) was measured. On D10, all heifers were inseminated, estrus manifestation was assessed and the preovulatory follicle (POF) was measured. On D20, the CL area was measured and blood flow was assessed using Doppler ultrasound. Data were analyzed by Student, Mann-Whitney or Friedman test. The rates of heat expression, ovulation, and blood flow score with Doppler were analyzed using Fisher's exact test and pregnancy rate by binary logistic regression model (P ≤ 0.05). There was no difference in AFC or AMH dosage (P > 0.05). Pró-Cio group had greater diameters of the DF (9.94 ± 0.42 mm) and POF (11.61 ± 0.56 mm) than the controls (DF: 7.72 ± 0.34 mm and POF: 9.91 ± 0.37 mm), as well a larger CL area (3.26 ± 0.26 versus 2.35 ± 0.16 cm2) and a higher mean CL vascularization score (3.06 versus 2.26; P < 0.05). There was no significant difference (P > 0.05) between estrus manifestation or conception rate for control and Pró-Cio groups. Heifers supplemented with the homeopathic product showed larger follicular diameters at the end of the FTAI protocol and CL with better blood flow scores compared to the control group.

Para esse estudo, novilhas ½ sangue Nelore x Aberdeen Angus (n = 40; 14 meses) foram divididas em dois grupos: Controle (n = 20; 310 kg) e Pró-cio (n = 20; 304 kg). Para o grupo Pró-Cio, 20 g/animal de produto homeopático (Pró-cio®, Real H, Campo Grande, Brazil) foi fornecido juntamente com o milho dezoito dias antes (D-18) de inicar o protocolo de inseminaçãoa artificial em tempo-fixo (IATF). No D0, todas as fêmeas receberam um dispositivo intravaginal de P4 e 2 mg BE. No D5, avaliou-se a contagem de folículos antrais (CFA) por ultrassonografia e realizou-se coleta de sangue para dosagem de AMH. No D8, procedeu-se a retirada do dispositivo de P4; aplicação de 300 UI de eCG, 0,530 mg de cloprostenol sódico e 0,5 mg de CE; um adesivo identificador de estro foi fixado na inserção da cauda e foi feita a mensuração do diâmetro do folículo dominante (FD). No D10, todas as novilhas foram inseminadas, foi realizada a avaliação da manifestação de estro e mensuração do folículo pré-ovulatório (FPO). No D20, realizou-se mensuração da área e avaliação do fluxo sanguíneo do CL por ultrassonografia Doppler. Os dados foram analisados pelos testes de Student, Mann-Whitney ou Friedman. As taxas de expressão de estro, ovulação e escore de fluxo sanguíneo com Doppler foram analisadas usando o teste exato de Fisher e taxa de prenhez pelo modelo de regressão logística binária (p ≤ 0,05). Não houve diferença na CFA nem na dosagem de AMH (p > 0,05). O grupo PróCio apresentou maior diâmetro do FD (9,94 ± 0,42 mm) e FPO (11,61 ± 0,56 mm) em relação ao controle (FD: 7,72 ± 0,34 mm e FPO: 9,91 ± 0,37 mm), além de maior área do CL (3,26 ± 0,26 versus 2,35 ± 0,16 cm2; p < 0,05) e maior escore de vascularização médio do CL (3,06 versus 2,26; p < 0,05). Não houve diferença (p > 0,05) na taxa de manifestação de estro e nem na taxa de concepção entre os grupos Controle e Pró-Cio, respectivamente. Novilhas suplementadas com o produto homeopático apresentaram maiores diâmetros foliculares ao final do protocolo de IATF e CL com melhores escores de fluxo sanguíneo em relação ao grupo controle.

Influence of eCG and reproductive management in the resynchronization of ovulation in dairy goats

Resynchronization protocols have been proposed as a way of shortening females' unproductive time in the flock, with good results in cattle and sheep. In goats, initial studies have shown that a second progestogen device inserted before luteolysis and pregnancy diagnosis does not interfere with the corpus luteum lifespan or functionality. This study aimed to evaluate the follicular growth, ovulation pattern and pregnancy rate after insertion of a second and new progestogen device for resynchronizing, with or without equine Chorionic Gonadotrophin (eCG), submitted to natural mating (NM) or artificial insemination (AI) to propose a viable resynchronization protocol for dairy goats. A total of 38 multiparous Saanen goats underwent a short-term progesterone protocol [six days exposed to medroxyprogesterone acetate (MAP) intravaginal sponges + 200 IU eCG and 0.12 mg of cloprostenol sodium on the 5th day + 0.025 mg of lecirelin 34 hours after sponge withdrawal] and, on day 16th after the ovulation, received a new MAP device which was retained until day 21. At this moment females were split into four groups: GeCG+NM ­ 100 IU eCG with NM; GSal+NM ­ saline solution with NM; GeCG+AI ­ 100 IU eCG with AI; and GSal+AI ­ saline solution with AI. Ultrasound scans were performed every 12 h from sponge withdrawal (day 21) until 108 h after sponge withdrawal (day 25) for follicular dynamics evaluation, at 240 h (day 31) for assessing the presence of active corpus luteum, and on day 60 for pregnancy diagnosis. No differences were found regarding ovulation time, synchronization and follicle size. However, GeCG+NM presented a greater estrus manifestation rate (100%) and pregnancy rate (62.5%) when compared to GSal+AI. In conclusion, resynchronization protocols in dairy goats may present satisfactory results.(AU)

Níveis de progesterona e os parâmetros reprodutivos no período periovulatório de vacas Nelore submetidas ao protocolo de IATF / Progesterone levels and reproductive parameters in the periovulatory period of Nellore cows under FTAI protocol

Background: Fixed Time Artificial Insemination (FTAI) has achieved a significant evolution in the last 18 years, however, despite the progress achieved by modern FTAI programs, the conception rates obtained are still low. Therefore, this study aimed to evaluate the interrelation between progesterone levels in the periovulatory period and reproductive parameters of Nellore cows submitted to an FTAI protocol. Materials, Methods & Results: On a random day, called day 0 (D0), 57 cows received a P4 device associated with the intramuscular (IM) application of 2.0 mg of estradiol benzoate. On D9, the P4 devices were removed and then were administered 500 µg of cloprostenol sodium IM; 0.6 mg of estradiol cypionate IM and 300 IUI of Equine Chorionic Gonadotrophin IM. Blood samples were collected for the determination of serum P4 concentrations on D9 and D11 of the protocol. The evaluations of follicular diameter (DFOL), follicular wall area (AFOL) and the vascularization area of the follicle wall (VFOL) were carried out on D11 using B-mode ultrasonography examination and colour Doppler, and then the artificial inseminations were performed. The evaluation of the corpus luteum diameter (CLD), of the total corpus luteum area (CLA), of the area of corpus luteum vascularization (CLV) and blood sampling for determination of postovulatory P4 levels (Post-P4) were performed on D24. For the analysis of the P4 concentration the chemiluminescence method was used, with a sensitivity of 0.1 ng/mL. According to the P4 concentrations on D11, cows were divided into 2 groups, LOW LEVELS OF P4 and HIGH LEVELS OF P4. The diagnosis of pregnancy was performed using transrectal ultrasonography on D45, at this point the cows were divided into 2 groups, PREGNANT and NON-PREGNANT. The correlation between DFOL and P4 dosage on D11 was moderate, negative and significant and between the AFOL and the serum P4 levels on D9, was moderate, negative and significant. As for the other correlations between follicular and luteal parameters and serum P4 levels, these were low to moderate, negative and not significant. Cows in the LOW LEVELS OF P4 group had significantly larger diameter and follicular areas than the cows in the HIGH LEVELS OF P4 group, the other follicular and luteal parameters showed no statistical difference. Of the total 57 cows that were inseminated, 30 cows became pregnant. Cows in the PREGNANT group had serum P4 levels on D9 equivalent to that obtained by the NON-PREGNANT group. However, at D11 the cows that became pregnant presented significantly lower serum P4 levels than cows that did not become pregnant. Discussion: The results of the interrelation between follicular parameters and P4 levels obtained in the present study, pointed out that the lower the levels of P4, the higher the follicular parameters, corroborating with other authors. Thus, larger preovulatory follicles provided high ovulation rates. Periovulatory serum P4 levels did not significantly affect the morphofunctional parameters of the CL. Such findings may be justified by high periovulatory P4 levels resulting from less efficient luteolysis, exert a negative effect on the results of FTAI protocols, because progesterone inhibits the release of LH pulses. It is concluded that lower periovulatory P4 levels established a favourable condition for follicular development and fertility, however, morphofunctional parameters of the corpus luteum were not affected.

Prostaglandin F2α as ovulatory stimulus in dairy cows and buffaloes raised in the Amazon biome / Prostaglandina F2α como estímulo ovulatório em vacas e búfalas leiteiras criadas no bioma Amazônia

This study evaluated the effect of a prostaglandin F2? (PGF) analogue as an ovulatory stimulus in dairy cows and buffaloes raised in the Amazon biome. To this end, three experiments were performed in the state of Rondônia, located in the Amazon biome. In Experiment 1, 22 lactating dairy buffaloes received 2 mg of intramuscular (I.M.) estradiol benzoate (EB) on day 0 and an intravaginal progesterone-releasing device (CIDR) from day 0 to day 9 of the protocol. On days 8 and 9, all cows were given 500 ?g of I.M. d-cloprostenol (PGF analogue). On day 10, buffaloes were divided into two groups to receive 500 ?g of PGF (PGF group, n = 8) or no treatment (CTL group, n = 14), respectively. In Experiment 2, 16 lactating crossbred dairy cows (Holstein x Gir) received 2 mg of EB on day 0 and a CIDR insert from day 0 to day 8. On days 7 and 8, all cows were given 500 ?g of d-cloprostenol. On day 9, cows were divided into two groups to receive 500 ?g of d-cloprostenol (PGF group, n = 8) or no treatment (CTL group, n = 8), respectively. In Experiment 3, 16 lactating crossbred dairy cows (Holstein x Gir) were handled and treated similarly as in Experiment 2, although cows did not receive d-cloprostenol on day 8. Single-point outcome variables were analyzed using one-way analysis of variance (ANOVA), while proportions with dichotomous outcomes were analyzed with the chi-square test.(AU)

O objetivo deste estudo foi avaliar o efeito de um análogo de prostaglandina F2α (PGF) como indutor ovulatório em vacas leiteiras e búfalas. Para este fim, três experimentos foram realizados no estado de Rondônia, localizado no bioma Amazônia. No Experimento 1, 22 búfalas leiteiras em lactação receberam 2 mg de benzoato de estradiol (EB) im, no Dia 0 e um dispositivo intravaginal de liberação de progesterona (CIDR) do Dia 0 ao Dia 9 do protocolo. Nos Dias 8 e 9, todas as vacas receberam 150μg de d-Cloprostenol (análogo PGF), im. No Dia 10, as búfalas foram divididas em dois grupos para receber 150μg de PGF (Grupo PGF, n = 8) ou nenhum tratamento (Grupo CTL, n = 14). No experimento 2, 16 vacas leiteiras mestiças (Holandês x Gir) receberam 2 mg de EB no Dia 0 e um dispositivo intravaginal (CIDR) do Dia 0 ao Dia 8. Nos Dias 7 e 8 todas as vacas receberam 150μg de d-Cloprostenol. No Dia 9, as vacas foram divididas em dois grupos para receber 150μg de d-Cloprostenol (Grupo PGF, n = 8) ou nenhum tratamento (Grupo CTL, n = 8). No Experimento 3, 16 vacas leiteiras mestiças (Holandês x Gir) foram tratadas da mesma forma que no Experimento 2, porém, as vacas não receberam d-Cloprostenol no Dia 8. Variáveis quantitativas foram analisados por análise de variância - one-way ANOVA e variáveis dicotômicas foram analisados pelo teste do qui-quadrado. No Experimento 1, não houve diferença (P = 0,30) na taxa de ovulação entre os grupos, em média 68% das búfalas ovularam após o tratamento. Além disso, não houve diferença entre os grupos no intervalo de ovulação (P = 0,61) e no diâmetro do folículo pré-ovulatório (P = 0,47). No Experimento 2, apenas uma vaca do Grupo PG não ovulou. Não houve diferenças no intervalo de ovulação entre os grupos CTL e PG (P = 0,69). Em média, a ovulação ocorreu 82 horas após a remoção do CIDR. No Experimento 3, vacas tratadas com PGF ovularam antes do Grupo CTL (62,5 ± 5,8 vs 94,5 ± 13,5 h; P = 0,05). Coletivamente, esses resultados sugeriram que a PGF antecipa a ovulação em vacas leiteiras em lactação, porém seu efeito não foi observado em búfalas.(AU)

Prostaglandin F2α as ovulatory stimulus in dairy cows and buffaloes raised in the Amazon biome / Prostaglandina F2α como estímulo ovulatório em vacas e búfalas leiteiras criadas no bioma Amazônia

This study evaluated the effect of a prostaglandin F2? (PGF) analogue as an ovulatory stimulus in dairy cows and buffaloes raised in the Amazon biome. To this end, three experiments were performed in the state of Rondônia, located in the Amazon biome. In Experiment 1, 22 lactating dairy buffaloes received 2 mg of intramuscular (I.M.) estradiol benzoate (EB) on day 0 and an intravaginal progesterone-releasing device (CIDR) from day 0 to day 9 of the protocol. On days 8 and 9, all cows were given 500 ?g of I.M. d-cloprostenol (PGF analogue). On day 10, buffaloes were divided into two groups to receive 500 ?g of PGF (PGF group, n = 8) or no treatment (CTL group, n = 14), respectively. In Experiment 2, 16 lactating crossbred dairy cows (Holstein x Gir) received 2 mg of EB on day 0 and a CIDR insert from day 0 to day 8. On days 7 and 8, all cows were given 500 ?g of d-cloprostenol. On day 9, cows were divided into two groups to receive 500 ?g of d-cloprostenol (PGF group, n = 8) or no treatment (CTL group, n = 8), respectively. In Experiment 3, 16 lactating crossbred dairy cows (Holstein x Gir) were handled and treated similarly as in Experiment 2, although cows did not receive d-cloprostenol on day 8. Single-point outcome variables were analyzed using one-way analysis of variance (ANOVA), while proportions with dichotomous outcomes were analyzed with the chi-square test.

O objetivo deste estudo foi avaliar o efeito de um análogo de prostaglandina F2α (PGF) como indutor ovulatório em vacas leiteiras e búfalas. Para este fim, três experimentos foram realizados no estado de Rondônia, localizado no bioma Amazônia. No Experimento 1, 22 búfalas leiteiras em lactação receberam 2 mg de benzoato de estradiol (EB) im, no Dia 0 e um dispositivo intravaginal de liberação de progesterona (CIDR) do Dia 0 ao Dia 9 do protocolo. Nos Dias 8 e 9, todas as vacas receberam 150μg de d-Cloprostenol (análogo PGF), im. No Dia 10, as búfalas foram divididas em dois grupos para receber 150μg de PGF (Grupo PGF, n = 8) ou nenhum tratamento (Grupo CTL, n = 14). No experimento 2, 16 vacas leiteiras mestiças (Holandês x Gir) receberam 2 mg de EB no Dia 0 e um dispositivo intravaginal (CIDR) do Dia 0 ao Dia 8. Nos Dias 7 e 8 todas as vacas receberam 150μg de d-Cloprostenol. No Dia 9, as vacas foram divididas em dois grupos para receber 150μg de d-Cloprostenol (Grupo PGF, n = 8) ou nenhum tratamento (Grupo CTL, n = 8). No Experimento 3, 16 vacas leiteiras mestiças (Holandês x Gir) foram tratadas da mesma forma que no Experimento 2, porém, as vacas não receberam d-Cloprostenol no Dia 8. Variáveis quantitativas foram analisados por análise de variância - one-way ANOVA e variáveis dicotômicas foram analisados pelo teste do qui-quadrado. No Experimento 1, não houve diferença (P = 0,30) na taxa de ovulação entre os grupos, em média 68% das búfalas ovularam após o tratamento. Além disso, não houve diferença entre os grupos no intervalo de ovulação (P = 0,61) e no diâmetro do folículo pré-ovulatório (P = 0,47). No Experimento 2, apenas uma vaca do Grupo PG não ovulou. Não houve diferenças no intervalo de ovulação entre os grupos CTL e PG (P = 0,69). Em média, a ovulação ocorreu 82 horas após a remoção do CIDR. No Experimento 3, vacas tratadas com PGF ovularam antes do Grupo CTL (62,5 ± 5,8 vs 94,5 ± 13,5 h; P = 0,05). Coletivamente, esses resultados sugeriram que a PGF antecipa a ovulação em vacas leiteiras em lactação, porém seu efeito não foi observado em búfalas.

Técnica de inseminação artificial por tração cervical e função luteal em ovelhas Santa Inês após estro sincronizado com cloprostenol ou progestágeno-eCG / Technique of artificial ins emination by cervical traction and luteal function in Santa Inês ewes after synchronized estrus with cloprostenol or progestagen-eCG

Avaliou-se a influência do protocolo de sincronização de estro na execução da técnica de inseminação artificial por tração cervical (ITC) e subsequente perfil sérico de progesterona em ovelhas Santa Inês. Um grupo foi submetido a duas aplicações de cloprostenol com sete dias de intervalo (PGF2α, n=43), outro grupo foi sincronizado com MAP-eCG (P4-eCG, n=40) e ovelhas ao estro natural (EN, n=10) formaram grupo controle. Com as ovelhas contidas em estação, foi realizada a técnica ITC utilizando um aplicador metálico e mandril. Foram avaliadas a profundidade de penetração e intensidade de reação da ovelha ao manejo da técnica. Dosagens de estradiol e progesterona foram feitas antes e depois da ITC/estro natural, respectivamente. Os níveis de estradiol foram superiores com P4-eCG vs PGF2α (P < 0,05), mas não houve influência do protocolo na execução da técnica. Ocorreram 83,5% de deposição intrauterina do sêmen, o tempo médio foi de 32 segundos e 90,7% das ovelhas apresentaram reação fraca ou moderada durante o manejo. Os níveis de progesterona foram semelhantes entre ITC e estro natural. Independente do protocolo hormonal, a técnica ITC em ovelhas Santa Inês mantidas em estação mostrou-se viável no tempo de penetração da cérvice e deposição intrauterina do sêmen, não comprometendo a função luteal subsequente.(AU)

The influence of estrus synchronization protocol was evaluated on the artificial insemination technique by cervical traction (ICT) and subsequent progesterone serum profile in Santa Inês ewes. One group was submitted to two applications of cloprostenol seven days apart (PGF2α, n=43), another group was synchronized with MAP-eCG (P4-eCG, n=40) and ewes at natural estrus (NE, n=10) formed a control group. With the ewe contained in the stand position, the ICT technique was performed using a metal applicator and mandrel. Depth of penetration and reaction intensity of the ewe to the handling of the technique were evaluated. Dosages of estradiol and progesterone were performed before and after ICT / natural estrus, respectively. Estradiol levels were higher with P4-eCG vs PGF2α(AU)

Técnica de inseminação artificial por tração cervical e função luteal em ovelhas Santa Inês após estro sincronizado com cloprostenol ou progestágeno-eCG / Technique of artificial ins emination by cervical traction and luteal function in Santa Inês ewes after synchronized estrus with cloprostenol or progestagen-eCG

Avaliou-se a influência do protocolo de sincronização de estro na execução da técnica de inseminação artificial por tração cervical (ITC) e subsequente perfil sérico de progesterona em ovelhas Santa Inês. Um grupo foi submetido a duas aplicações de cloprostenol com sete dias de intervalo (PGF2α, n=43), outro grupo foi sincronizado com MAP-eCG (P4-eCG, n=40) e ovelhas ao estro natural (EN, n=10) formaram grupo controle. Com as ovelhas contidas em estação, foi realizada a técnica ITC utilizando um aplicador metálico e mandril. Foram avaliadas a profundidade de penetração e intensidade de reação da ovelha ao manejo da técnica. Dosagens de estradiol e progesterona foram feitas antes e depois da ITC/estro natural, respectivamente. Os níveis de estradiol foram superiores com P4-eCG vs PGF2α (P < 0,05), mas não houve influência do protocolo na execução da técnica. Ocorreram 83,5% de deposição intrauterina do sêmen, o tempo médio foi de 32 segundos e 90,7% das ovelhas apresentaram reação fraca ou moderada durante o manejo. Os níveis de progesterona foram semelhantes entre ITC e estro natural. Independente do protocolo hormonal, a técnica ITC em ovelhas Santa Inês mantidas em estação mostrou-se viável no tempo de penetração da cérvice e deposição intrauterina do sêmen, não comprometendo a função luteal subsequente.

The influence of estrus synchronization protocol was evaluated on the artificial insemination technique by cervical traction (ICT) and subsequent progesterone serum profile in Santa Inês ewes. One group was submitted to two applications of cloprostenol seven days apart (PGF2α, n=43), another group was synchronized with MAP-eCG (P4-eCG, n=40) and ewes at natural estrus (NE, n=10) formed a control group. With the ewe contained in the stand position, the ICT technique was performed using a metal applicator and mandrel. Depth of penetration and reaction intensity of the ewe to the handling of the technique were evaluated. Dosages of estradiol and progesterone were performed before and after ICT / natural estrus, respectively. Estradiol levels were higher with P4-eCG vs PGF2α

The role of prostaglandin F2α on ovulation and LH release in cows / A função da prostaglandina F2α na ovulação e na liberação de LH em vacas

This study aimed to evaluate the role of prostaglandin F2α (PGF) on ovulation. In Experiment 1, cows were randomly allocated to two treatments to receive 150 µg of d-Cloprostenol (PGF Group, n = 12) or 2 mL of NaCl 0.9% (Control Group, n = 11) and CIDRs, were removed 4 days later. No cow ovulated in Control and PGF groups. In Experiment 2, cows were randomly separated into two experimental groups to receive 4 injections of 150 µg of d-Cloprostenol (n = 9) or 2 mL of NaCL 0.9% (n = 9). In this experiment, ovulation was not observed in any cows. In Experiment 3, ovariectomized cows receive three injections of 300µg of PGF analog (PGF Group, n = 5), 100µg of Lecirelin (GnRH Group, n = 5) or 2 mL of PBS (Control Group, n = 4). The LH concentration was higher (P <0.0001) in cows from the GnRH group than in the PGF and Control groups. In experiment 4, cows with preovulatory follicles (>11.5 mm) were treated with Saline (Control Group, n = 6); Lecirelin (GnRH Group, n = 7) or Cloprostenol Sodium (PGF Group, n = 6). There was a significant increase in the vascular area of follicles from 0 to 24 h in GnRH and PGF treatments. In conclusion, PGF was not able to induce ovulation in cows with high or low plasma progesterone concentration. Additionally, PGF alone was not able to induce LH release and follicle luteinization, but increased follicular vascularization.(AU)

O objetivo deste estudo foi avaliar o papel da prostaglandina F2α (PGF) na ovulação. No Experimento 1, as vacas foram alocadas aleatoriamente em dois tratamentos para receber 150 µg de d-Cloprostenol (Grupo PGF, n = 12) ou 2 mL de NaCl 0,9% (Grupo Controle, n = 11) e os CIDR, foram removidos 4 dias depois. Nenhuma vaca ovulou nos grupos Controle e PGF. No Experimento 2, as vacas foram separadas aleatoriamente em dois grupos experimentais para receber 4 injeções de 150 µg de d-Cloprostenol (n = 9) ou 2 mL de NaCL 0,9% (n = 9). Não foi observada ovulação em nenhum dos animais deste experimento. No Experimento 3, vacas ovariectomizadas receberam três injeções de 300µg de análogo de PGF (Grupo PGF, n = 5), 100µg de Lecirelina (Grupo GnRH, n = 5) ou 2 mL de PBS (Grupo Controle, n = 4). A concentração de LH foi maior (P <0,0001) nas vacas do grupo GnRH do que nos grupos PGF e Controle. No Experimento 4, vacas com folículos pré-ovulatórios (> 11,5 mm) foram tratadas com solução salina (Grupo Controle, n = 6), Lecirelina (Grupo GnRH, n = 7) ou Cloprostenol Sódico (Grupo PGF, n = 6). Houve um aumento significativo na área vascular dos folículos de 0 a 24h nos tratamentos com GnRH e PGF. Em conclusão, a PGF não foi capaz de induzir ovulação em vacas com alta ou baixa concentração plasmática de progesterona. Além disso, a PGF sozinha não foi capaz de induzir a liberação de LH e a luteinização do folículo, mas aumentou a vascularização folicular.(AU)

The role of prostaglandin F2α on ovulation and LH release in cows / A função da prostaglandina F2α na ovulação e na liberação de LH em vacas

This study aimed to evaluate the role of prostaglandin F2α (PGF) on ovulation. In Experiment 1, cows were randomly allocated to two treatments to receive 150 µg of d-Cloprostenol (PGF Group, n = 12) or 2 mL of NaCl 0.9% (Control Group, n = 11) and CIDRs, were removed 4 days later. No cow ovulated in Control and PGF groups. In Experiment 2, cows were randomly separated into two experimental groups to receive 4 injections of 150 µg of d-Cloprostenol (n = 9) or 2 mL of NaCL 0.9% (n = 9). In this experiment, ovulation was not observed in any cows. In Experiment 3, ovariectomized cows receive three injections of 300µg of PGF analog (PGF Group, n = 5), 100µg of Lecirelin (GnRH Group, n = 5) or 2 mL of PBS (Control Group, n = 4). The LH concentration was higher (P <0.0001) in cows from the GnRH group than in the PGF and Control groups. In experiment 4, cows with preovulatory follicles (>11.5 mm) were treated with Saline (Control Group, n = 6); Lecirelin (GnRH Group, n = 7) or Cloprostenol Sodium (PGF Group, n = 6). There was a significant increase in the vascular area of follicles from 0 to 24 h in GnRH and PGF treatments. In conclusion, PGF was not able to induce ovulation in cows with high or low plasma progesterone concentration. Additionally, PGF alone was not able to induce LH release and follicle luteinization, but increased follicular vascularization.(AU)

O objetivo deste estudo foi avaliar o papel da prostaglandina F2α (PGF) na ovulação. No Experimento 1, as vacas foram alocadas aleatoriamente em dois tratamentos para receber 150 µg de d-Cloprostenol (Grupo PGF, n = 12) ou 2 mL de NaCl 0,9% (Grupo Controle, n = 11) e os CIDR, foram removidos 4 dias depois. Nenhuma vaca ovulou nos grupos Controle e PGF. No Experimento 2, as vacas foram separadas aleatoriamente em dois grupos experimentais para receber 4 injeções de 150 µg de d-Cloprostenol (n = 9) ou 2 mL de NaCL 0,9% (n = 9). Não foi observada ovulação em nenhum dos animais deste experimento. No Experimento 3, vacas ovariectomizadas receberam três injeções de 300µg de análogo de PGF (Grupo PGF, n = 5), 100µg de Lecirelina (Grupo GnRH, n = 5) ou 2 mL de PBS (Grupo Controle, n = 4). A concentração de LH foi maior (P <0,0001) nas vacas do grupo GnRH do que nos grupos PGF e Controle. No Experimento 4, vacas com folículos pré-ovulatórios (> 11,5 mm) foram tratadas com solução salina (Grupo Controle, n = 6), Lecirelina (Grupo GnRH, n = 7) ou Cloprostenol Sódico (Grupo PGF, n = 6). Houve um aumento significativo na área vascular dos folículos de 0 a 24h nos tratamentos com GnRH e PGF. Em conclusão, a PGF não foi capaz de induzir ovulação em vacas com alta ou baixa concentração plasmática de progesterona. Além disso, a PGF sozinha não foi capaz de induzir a liberação de LH e a luteinização do folículo, mas aumentou a vascularização folicular.(AU)

Use of cooled buffalo semen as a strategy to increase conception rates in fixed-time artificial insemination programs during unfavorable reproductive periods / [Uso de sêmen resfriado de búfalo como estratégia para aumentar as taxas de concepção em programas de inseminação artificial em tempo fixo, durante períodos reprodutivos desfavoráveis]

The objective of this study was to compare the reproductive efficiency of dairy buffaloes undergoing fixed-time artificial insemination (FTAI) protocols based on progesterone/estrogen (P4/E2) and eCG during unfavorable breeding season using cooled (CS) and frozen semen (FS). A total of 446 buffaloes (> 40 days postpartum) were randomly distributed into four blocks (years): B1-2014 (n = 143), B2-2015 (n = 34), B3-2016 (n = 90), and B4-2017 (n = 179). Each block was subdivided into two (AI with CS and FS using the same ejaculate of each bull). Thus, the block subdivision was as follows: B1 (CS = 71 and FS = 72); B2 (CS = 18 and FS = 16); B3 (CS = 47 and FS = 43); and B4 (CS = 90 and FS = 89). The ejaculates of eight Murrah bulls collected using an artificial vagina were divided into two aliquots: one aliquot was diluted in Botu-Bov® commercial extender and cooled (BB-CS), and the other was diluted in the same extender and frozen (BB-FS). BB-CS aliquots were cooled at 5 °C/24 h using a refrigerator. BB-FS group aliquots were also cooled, and after equilibrating at 5 °C for 4 h, were placed in a 21-L Styrofoam box, 5 cm above the surface of liquid nitrogen. In the afternoon (A) on D0 (2:00 p.m.) the animals received EB 2.0 mg IM (Estrogin®) and an ear implant (CRESTAR® 3.0 mg P4). At D9 (A), the implant was removed, and the animals received eCG 400 IU IM (Folligon® 5000) + Cloprostenol PGF2α 0.530 mg IM (Sincrocio®). At D10 (A), the animals received EB 1.0 mg IM (Estrogin®), and at D12 (8:00 a.m.), AI was performed. At D42, pregnancy was diagnosed via ultrasonography. Total CRs were 48.2% CS and 34.6% FS for years 2014 to 2017, with a significant difference of 13.7% (P<0.05). In conclusion, cooled semen resulted in higher CR than frozen semen in dairy buffaloes under the P4/E2 and eCG FTAI during the unfavorable reproductive season.(AU)

O objetivo deste estudo foi comparar a eficiência reprodutiva de búfalas leiteiras submetidas a protocolos de inseminação artificial em tempo fixo (IATF) à base de progesterona/estrogênio (P4/E2) e eCG, durante a estação reprodutiva desfavorável, usando-se sêmen resfriado (SR) e congelado (SC) Um total de 446 búfalas (> 40 dias após o parto) foi distribuído aleatoriamente em quatro blocos (anos): B1-2014 (n = 143), B2-2015 (n = 34), B3-2016 (n = 90) e B4-2017 (n = 179). Cada bloco foi subdividido em dois (IA com SR e SC utilizando-se a mesma ejaculação de cada touro). Assim, a subdivisão do bloco foi a seguinte: B1 (SR = 71 e SC = 72); B2 (SR = 18 e SC = 16); B3 (SR = 47 e SC = 43); e B4 (SR = 90 e SC = 89). Os ejaculados de oito touros Murrah coletados com vagina artificial foram divididos em duas alíquotas: uma alíquota diluída em diluente comercial Botu-Bov® e resfriada (BB-SR), e a outra diluída no mesmo diluente e congelada (BB-SC). As alíquotas de BB-SR foram resfriados a 5°C/24h usando-se um refrigerador. As alíquotas do grupo BB-SC também foram resfriadas e, após equilíbrio a 5°C por 4h, foram colocadas em uma caixa de isopor de 21L, 5 cm acima da superfície do nitrogênio líquido. À tarde (A), no D0 (14h), os animais receberam BE 2,0 mg IM (Estrogin®) e um implante auricular (Crestar® 3,0 mg P4). No D9 (A), o implante foi retirado e os animais receberam eCG 400 UI IM (Folligon® 5000) + cloprostenol PGF2α 0,530 mg IM (Sincrocio®). No D10 (A), os animais receberam BE 1,0mg IM (Estrogin®), e, no D12 (8h da manhã), foram realizadas as IAs. No D42, a gestação foi diagnosticada por ultrassonografia. As taxas de concepção (TC) totais foram 48,2% SR e 34,6% SC para os anos de 2014 a 2017, com uma diferença significativa de 13,7% (P<0,05). Em conclusão, o sêmen resfriado resultou em maior TC do que o sêmen congelado em bubalinos leiteiros sob P4/E2 e eCG FTAI durante a estação reprodutiva desfavorável.(AU)

Efeito da expressão do estro sobre características morfofuncionais foliculares, luteais e fertilidade em fêmeas Bos indicus sincronizadas para IATF / Effect of the estrus expression on follicular and luteal morphofunctional characteristics and fertility in Bos indicus females synchronized for FTAI

Background: Recent studies have been conducted with the aim of improving the fertility rates in the FTAI programsin beef females. The observation of the estrus expression constitutes an important indicator of fertility in zebu females.Therefore, this work has as an objective to evaluate the impact of the estrus expression on the follicular, luteal and fertilitymorphofunctional characteristics of Nelore females synchronized for FTAI.Materials, Methods & Results: Sixty five lactating female Nelore (Bos taurus indicus) were used. On a random day, denominatedday 0 (D0), the 65 Nelore females received a progesterone-releasing device associated to the application of 2.0 mg of estradiolbenzoate intramuscularly (IM). On D9, the progesterone-releasing intravaginal devices were removed and was administered500 μg of cloprostenol sodium IM; 0.6 mg of estradiol cypionate IM and 300 UI of Equine Chorionic Gonadotropin IM. At thispoint, the animals were marked with a marking stick for the determination of the estrus expression. On D11 of the synchronization protocol, the animals were characterized in two groups: without estrus expression WITHOUT ESTRUS and with estrusexpression WITH ESTRUS. The evaluation of the follicle diameter (FOLD), of the follicle wall area (FOLA), of the folliclewall vascularization (FOLV) and the percentage of vascularization in the area of the preovulatory follicle wall (%FOLV) wereconducted on D11 using B-mode ultrasonography and color Doppler and then the artificial inseminations were performed. Theevaluation of the corpus luteum diameter (CLD), the total area of the corpus luteum (CLA), of the area of vascularization of thecorpus luteum (CLV), of the percentage of vascularization of the in the area of the corpus luteum (% CLV) and the collectionof blood for the evaluation of the serum...

Efeito da expressão do estro sobre características morfofuncionais foliculares, luteais e fertilidade em fêmeas Bos indicus sincronizadas para IATF / Effect of the estrus expression on follicular and luteal morphofunctional characteristics and fertility in Bos indicus females synchronized for FTAI

Background: Recent studies have been conducted with the aim of improving the fertility rates in the FTAI programsin beef females. The observation of the estrus expression constitutes an important indicator of fertility in zebu females.Therefore, this work has as an objective to evaluate the impact of the estrus expression on the follicular, luteal and fertilitymorphofunctional characteristics of Nelore females synchronized for FTAI.Materials, Methods & Results: Sixty five lactating female Nelore (Bos taurus indicus) were used. On a random day, denominatedday 0 (D0), the 65 Nelore females received a progesterone-releasing device associated to the application of 2.0 mg of estradiolbenzoate intramuscularly (IM). On D9, the progesterone-releasing intravaginal devices were removed and was administered500 μg of cloprostenol sodium IM; 0.6 mg of estradiol cypionate IM and 300 UI of Equine Chorionic Gonadotropin IM. At thispoint, the animals were marked with a marking stick for the determination of the estrus expression. On D11 of the synchronization protocol, the animals were characterized in two groups: without estrus expression WITHOUT ESTRUS and with estrusexpression WITH ESTRUS. The evaluation of the follicle diameter (FOLD), of the follicle wall area (FOLA), of the folliclewall vascularization (FOLV) and the percentage of vascularization in the area of the preovulatory follicle wall (%FOLV) wereconducted on D11 using B-mode ultrasonography and color Doppler and then the artificial inseminations were performed. Theevaluation of the corpus luteum diameter (CLD), the total area of the corpus luteum (CLA), of the area of vascularization of thecorpus luteum (CLV), of the percentage of vascularization of the in the area of the corpus luteum (% CLV) and the collectionof blood for the evaluation of the serum...(AU)

Comparison of three doses of estradiol benzoate for synchronization of follicular wave emergence in suckled Bos indicus beef cows

We aimed to compare the effect of three estradiol benzoate (EB) doses on follicular wave emergence (FWE) and dominant follicle growth of suckled Nelore cows submitted to TAI (D0). On a random day of estrous cycle (D−10), multiparous (MULT; n=36) and primiparous (PRIM; n=20) suckled Nelore cows received an intravaginal progesterone (P4) device and were assigned in three groups. Cows in the EB-1 (n=20), EB-1.5 (n=15) or EB-2 (n=21) groups received, respectively, an im treatment with 1, 1.5 or 2 mg EB. A subgroup (n=10-13 cows/group) were subject to daily ovarian evaluations from D−10 to D0. On D−2, P4 devices were removed, and all cows received the same treatment: 1 mg estradiol cypionate, 0.53 mg sodium cloprostenol, and 300 IU eCG. Statistical analyses were performed considering only the main effects of treatment group and parity order. The proportion of cows with a synchronized FWE and the moment of the FWE did not differ (p>0.05) among the treatment groups (overall: 80% [28/35] and 4.1 ± 0.4 days); however, the FWE occurred earlier (p=0.007) in MULT (3.8 ± 0.2 days) than PRIM (5.1 ± 0.4) cows. The proportion of animals detected in estrus was greater (86% [31/36] vs. 70% [14/20]; p=0.02) and the dominant follicle was larger on D−2 (9.7 ± 0.3 mm vs. 7.8 ± 0.7 mm; p=0.006) and D0 (11.9 ± 0.4 mm vs. 10 ± 0.5 mm; p=0.008) in MULT than PRIM cows. In conclusion, the three EB doses presented similar efficiency to synchronize the FWE in suckled Nelore cows. Moreover, a delayed FWE and smaller dominant follicle is observed in PRIM cows, contributing to the reduced reproductive performance in this parity category when using similar TAI protocols of MULT cows.

The effect of Gonadotropin releasing hormone administration on fertility and embryonic loss in goats during the anoestrus period

Following the induction of oestrus out of season in small ruminants, low fertility and variations in fertility rates are associated with embryonic losses. One of the main causes of embryonic loss is luteal dysfunction. Gonadotropin Releasing Hormone (GnRH) supports the luteal structure, and increasing progesterone levels may be beneficial in terms of promoting embryonic life. The main objective of the present study was to evaluate the efficacy of GnRH administration following an oestrus induction protocol in the anoestrus season for preventing embryonic loss in goats having failure to conceive during the season. In the study, 106 Damascus goats aged 3-5 years and weighing 45-60 kg were used. The oestrus of 106 goats in the anoestrous group was stimulated with progesterone and pregnant mare serum gonadotropin (PMSG) treatment. Out of breeding season, goats were divided into the 4 following groups: GnRH0 (n = 27), GnRH7 (n = 26), GnRH0+7 (n = 27) and control (n = 26). In each goat, an intravaginal sponge (IS) containing 20 mg of fluorogestone acetate (FGA) was placed into the vagina and left for 9 days. With the withdrawal of the sponge, 550IU PMSG and 125 µg of d-cloprostenol were injected intramuscularly. Oestrus detection was made via teaser bucks for 3 days starting 24 h after withdrawal of the IS. Eighteen bucks known to be fertile were used for breeding. Goats in the oestrus period were mated via natural breeding. The GnRH analogue lecirelin was injected intramuscularly at breeding in the GnRH0 group, on day 7 post-breeding in the GnRH7 group, and both at breeding and on day 7 post-breeding in the GnRH0+7 group. No injections were given to the control group. Blood samples for progesterone measurement were taken by jugular vena puncturing on days 3, 6, 7, 10, 13, 16, and 19 after breeding from 10 randomly chosen goats in all groups. The goats with a level of > 3.5 ng/mL of progesterone on day 21 post-breeding were evaluated as pregnant. Pregnancy was also viewed on day 50 after breeding by real-time ultrasonography (USG) with a 5-7.5 MHz convex probe. The oestrus rate was 96.23% (102/106) in the goats. The rates of onset of oestrus between 36-48 h, 48-60 h and 60 h and beyond were 38.7% (41/106), 21.7% (23/106) and 35.8% (38/106), respectively. The total pregnancy rate was 35.8% (38/106). There were no statistically significant differences (P > 0.05) found for the pregnancy rate, embryonic death rate or progesterone concentration of the groups. However, serum progesterone levels were statistically different in the GnRH7 group compared with the control group (P < 0.05). After synchronisation, various anti-luteolytic strategies can be used to support corpus luteum development and elevate progesterone concentration in the luteal phase to decrease embryonic loss and increase reproductive performance. Therefore, application of GnRH to support the luteal structure and to increase progesterone levels may be beneficial in terms of supporting embryonic life. The results showed that GnRH treatment on the day 7 post-breeding following oestrus induction, including FGA and PMSG, can increase serum progesterone levels in Damascus goats in the anoestrus period. However, following oestrus induction in the anoestrus period, it was seen that GnRH treatment at breeding or on day 7 after breeding did not have any positive effect on embryonic loss or reproductive performance. In conclusion, it was considered that this protocol could be implemented successfully, yielding a 35% pregnancy rate in Damascus goats in the anoestrus period, but embryonic loss must be deeply studied in detail.(AU)

Comparison of three doses of estradiol benzoate for synchronization of follicular wave emergence in suckled Bos indicus beef cows

We aimed to compare the effect of three estradiol benzoate (EB) doses on follicular wave emergence (FWE) and dominant follicle growth of suckled Nelore cows submitted to TAI (D0). On a random day of estrous cycle (D−10), multiparous (MULT; n=36) and primiparous (PRIM; n=20) suckled Nelore cows received an intravaginal progesterone (P4) device and were assigned in three groups. Cows in the EB-1 (n=20), EB-1.5 (n=15) or EB-2 (n=21) groups received, respectively, an im treatment with 1, 1.5 or 2 mg EB. A subgroup (n=10-13 cows/group) were subject to daily ovarian evaluations from D−10 to D0. On D−2, P4 devices were removed, and all cows received the same treatment: 1 mg estradiol cypionate, 0.53 mg sodium cloprostenol, and 300 IU eCG. Statistical analyses were performed considering only the main effects of treatment group and parity order. The proportion of cows with a synchronized FWE and the moment of the FWE did not differ (p>0.05) among the treatment groups (overall: 80% [28/35] and 4.1 ± 0.4 days); however, the FWE occurred earlier (p=0.007) in MULT (3.8 ± 0.2 days) than PRIM (5.1 ± 0.4) cows. The proportion of animals detected in estrus was greater (86% [31/36] vs. 70% [14/20]; p=0.02) and the dominant follicle was larger on D−2 (9.7 ± 0.3 mm vs. 7.8 ± 0.7 mm; p=0.006) and D0 (11.9 ± 0.4 mm vs. 10 ± 0.5 mm; p=0.008) in MULT than PRIM cows. In conclusion, the three EB doses presented similar efficiency to synchronize the FWE in suckled Nelore cows. Moreover, a delayed FWE and smaller dominant follicle is observed in PRIM cows, contributing to the reduced reproductive performance in this parity category when using similar TAI protocols of MULT cows.(AU)

Influência da progesterona injetável na taxa de prenhez e perda gestacional de fêmeas nelore de distintas categorias reprodutivas submetidas a inseminação artificial em tempo fixo / Influence of injectable progesterone on the pregnancy rate and gestational loss of Nellore females of different reproductive categories undergoing fixed-time artificial insemination

Progesterone (P4) is essential for embryonic development and maintenance of pregnancy when deficiency causes early embryonic loss. In this study, we investigated the ability of hormonal supplementation to improve the fertility of Nellore females subjected to fixed-time artificial insemination (IATF) protocols. Here, we evaluated the effect of long-acting injectable progesterone (iP4) supplementation in the D4 after IATF on pregnancy rate and pregnancy loss in Nellore females (Bos taurus indicus) from different reproductive categories in Western Amazonia. Eight hundred thirteen Nellore females from 5 farms were selected and distributed into 2 groups: control [GC; administration of 0.5 mL of 0.9% saline solution, intramuscularly - IM] (n = 407) and a group that received injectable progesterone (iP4) that was long-acting [GiP4; administration of 0.5 mL of iP4, 300 mg, via IM four days after IATF] (n = 406). Each group contained 3 subgroups: heifers, primiparous cows, and multiparous cows. Of the 407 animals in the CG, 103 were heifers, 107 primiparous, and 197 multiparous. Of the 406 animals in the GiP4 group, there were 101 heifers, 107 primiparous, and 198 multiparous. On a random day of the estrous cycle (D0), an intravaginal device containing 1 g of P4 and 2 mg of estradiol benzoate (BE) was inserted by intramuscular injection. On D8, the P4 device was removed and 150 µg of D-cloprostenol (PGF2α), 300 IU eCG, and 1 mg BE were administered IM. Cows were inseminated at D10, 48-52 h after procedure on D8. Pregnancy diagnosis was made between 35 and 40 days after insemination through ultrasound examination. Between 80 and 90 days after insemination, a new ultrasound examination was performed to assess early pregnancy loss. The data were processed using the SAS 9.2. The conception rate, pregnancy loss, and final conception rate were analyzed using PROC GLIMMIX according to groups (CG and GiP4), categories (heifers, primiparous and multiparous), and their interactions as variables. The differences in the means of least squares were adjusted using the Tukey­Kramer method. Statistical significance was defined as P < 0.05. The general conception rate was 46% (375/816). Regardless of the animal class, GiP4 animals (51.97%) had higher conception rates (P < 0.05) than CG (40.29%). In the subgroups (heifers, primiparous and multiparous cows), there was a difference (P < 0.05) between animals treated with iP4 (52.48%, 57.94%, and 48.48%, respectively) and those who were not (39.81%, 41.12%, and 40.10%, respectively). Gestational losses, regardless of the animal class, were higher in females in the CG (7.93%) [P < 0.05] compared to those in the GiP4 group (2.84%). Regardless of treatment with iP4, the percentage of gestational loss in heifers was significantly higher (10.64%) than that in primiparous and multiparous cows (3.77% and 2.86%, respectively). The final conception rates were higher in animals that received long-acting iP4, which increased the final pregnancy in all parity categories. In the present study, the use of iP4 increased the pregnancy rate in Nellore females, regardless of the category. Although there has been no consensus on the use of iP4, there is an agreement that increases in the pregnancy rate are related to the moment of exogenous P4 application. In addition to influencing the pregnancy rate, reduction in pregnancy losses is also attributed to iP4 treatment, a fact demonstrated in the present study, where animals treated with iP4 had a lower pregnancy loss rate than normally occurs in beef cattle. Supplementation with long-acting iP4 increased the pregnancy rate at D35-40, reduced pregnancy losses, and increased the conception rate on D80-90 days in Nellore females reared in the Western Amazon, regardless of the animal category.(AU)

Avaliação do acetato de melengestrol (MGA) na sincronização do estro em fêmeas de veado-mão-curta (Mazama nana) e veado-roxo (Mazama nemorivaga): estudo piloto / Assessment of melengestrol acetate on estrus synchronization in female of Brazilian dwarf brocket deer and Amazonian brown brocket deer: pilot study

A introdução de dispositivos intravaginais em protocolos tradicionais de sincronização do estro (SE) exige contenção física e/ou química, o que pode resultar em estresse e efeitos negativos na fisiologia reprodutiva de animais selvagens. Portanto, o uso de protocolos não invasivos pode ser mais eficaz para o manejo da reprodução ex situ. O objetivo deste estudo foi avaliar a eficácia do acetato de melengestrol (MGA), na SE de uma fêmea de veado-mão-curta (Mazama nana) e uma de veado-roxo (Mazama nemorivaga). Ambas receberam uma aplicação via intramuscular de 0,25 mg de benzoato de estradiol (Sincrodiol® ) no dia 0 (D0). Entre o D0 e o D7, foi administrado 1 mg/animal/dia de MGA® Premix fracionado em duas porções (0,5 mg pela manhã e 0,5 mg a tarde), misturadas com banana. No D8, um análogo de PGF2α (Cloprostenol - Ciosin® ) foi administrado via intramuscular. Após o tratamento, o estro comportamental (EC) foi avaliado com auxílio de um macho da respectiva espécie desde D9 a D13, primeiramente a cada seis horas e, após o início do EC, a cada quatro horas. As duas fêmeas apresentaram sinais de EC nos dias 12 e 13. Na espécie Mazama nana, o EC teve uma duração aproximada de 16 horas e, na espécie Mazama nemorivaga, 20 horas. Os resultados obtidos neste estudo sugerem a eficácia da dose de 1,0 mg/animal/dia de MGA, fracionada em duas doses, na manipulação estral em fêmeas de veado-mão-curta e veado-roxo, uma vez que ambas demonstraram EC quatro dias após o protocolo de sincronização proposto.(AU)

The introduction of intravaginal devices in traditional estrus synchronization protocols requires physical and/or chemical restraint, which can result in stress and negative effects on the reproductive physiology of wild animals. Therefore, the use of non-invasive protocols might be more effective for the reproductive management ex situ. The objective of this study was to evaluate the efficacy of the melengestrol acetate (MGA) for estrus synchronization of two females: one deer-short-hand (Mazama nana) and one deer-purple (Mazama nemorivaga). Both were given an application of estradiol benzoate (Sincrodiol® ) on day 0 (D0). From D0 to D7, 1 mg/female/day of oral MGA® Premix was fractionated in two administrations (0.5 mg morning and 0.5mg afternoon) mixed with banana. On D8, a PGF2α analogue were given intramuscularly (Cloprostenol - Ciosin® ). After treatment, behavioural estrus was evaluated with the aid of a male of the respective species from D9 to D13, initially every six hours then every four hours after the onset of behavioural estrus. The two females showed behavioural estrus on days 12 and 13. In the Mazama nana, the behavioral estrus had duration of approximately 16 hours and in the Mazama nemorivaga 20 hours. The results obtained in this study suggest the efficacy of 1.0 mg/female/day of MGA fractionated in two doses for the estrus manipulation in deer-short-hand and deer-purple females, since both showed behavioural estrus four days after the proposed synchronization protocol.(AU)